These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26798129)

  • 1. Comment on Giacco et al. GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop. Diabetes 2015;64:3273-3284.
    Ceriello A; Genovese S
    Diabetes; 2016 Feb; 65(2):e5. PubMed ID: 26798129
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Giacco et al. GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop. Diabetes 2015;64:3273-3284.
    Brownlee M
    Diabetes; 2016 Feb; 65(2):e6-7. PubMed ID: 26798130
    [No Abstract]   [Full Text] [Related]  

  • 3. GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop.
    Giacco F; Du X; Carratú A; Gerfen GJ; D'Apolito M; Giardino I; Rasola A; Marin O; Divakaruni AS; Murphy AN; Shah MS; Brownlee M
    Diabetes; 2015 Sep; 64(9):3273-84. PubMed ID: 26294429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis.
    Kim DI; Park MJ; Choi JH; Lim SK; Choi HJ; Park SH
    Int J Biochem Cell Biol; 2015 Feb; 59():41-51. PubMed ID: 25483438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
    Yan F; Zhang GH; Feng M; Zhang W; Zhang JN; Dong WQ; Zhang C; Zhang Y; Chen L; Zhang MX
    Mol Med; 2015 Feb; 21(1):15-25. PubMed ID: 25715248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
    Dai Y; Mercanti F; Dai D; Wang X; Ding Z; Pothineni NV; Mehta JL
    Biochem Biophys Res Commun; 2013 Jul; 437(1):62-6. PubMed ID: 23806684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species].
    Nishikawa T; Araki E
    Rinsho Byori; 2008 Aug; 56(8):712-9. PubMed ID: 18800628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line.
    Sancho V; Daniele G; Lucchesi D; Lupi R; Ciccarone A; Penno G; Bianchi C; Dardano A; Miccoli R; Del Prato S
    PLoS One; 2017; 12(11):e0187836. PubMed ID: 29121068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions.
    Fukuda S; Nakagawa S; Tatsumi R; Morofuji Y; Takeshita T; Hayashi K; Tanaka K; Matsuo T; Niwa M
    J Mol Neurosci; 2016 Jun; 59(2):211-9. PubMed ID: 26659380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro.
    Zheng Z; Chen H; Zhao H; Liu K; Luo D; Chen Y; Chen Y; Yang X; Gu Q; Xu X
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):64-71. PubMed ID: 19696171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome, mTORC1 activation, and metabolic derangement contribute to the susceptibility of diabetics to infections.
    Krakauer T
    Med Hypotheses; 2015 Dec; 85(6):997-1001. PubMed ID: 26384528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1.
    Sada K; Nishikawa T; Kukidome D; Yoshinaga T; Kajihara N; Sonoda K; Senokuchi T; Motoshima H; Matsumura T; Araki E
    PLoS One; 2016; 11(7):e0158619. PubMed ID: 27383386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycaemia modifies energy metabolism and reactive oxygen species formation in endothelial cells in vitro.
    Dymkowska D; Drabarek B; Podszywałow-Bartnicka P; Szczepanowska J; Zabłocki K
    Arch Biochem Biophys; 2014 Jan; 542():7-13. PubMed ID: 24295959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia.
    Yano M; Hasegawa G; Ishii M; Yamasaki M; Fukui M; Nakamura N; Yoshikawa T
    Redox Rep; 2004; 9(2):111-6. PubMed ID: 15231066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of reactive oxygen species in TLR-stimulated granulocytes is not enhanced by hyperglycemia in diabetes.
    Fagundes-Netto FS; Anjos PM; Volpe CM; Nogueira-Machado JA
    Int Immunopharmacol; 2013 Nov; 17(3):924-9. PubMed ID: 24121038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.
    Zander M; Madsbad S; Deacon CF; Holst JJ
    Diabetologia; 2006 Feb; 49(2):369-74. PubMed ID: 16385384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress.
    Gustafsson H; Söderdahl T; Jönsson G; Bratteng JO; Forsby A
    J Neurosci Res; 2004 Jul; 77(2):285-91. PubMed ID: 15211595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetes.
    Ross SA; Ballantine J
    Curr Med Res Opin; 2013 Dec; 29(12):1617-26. PubMed ID: 23971789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.